Literature DB >> 12891649

The lumbar puncture for diagnosis of pediatric neurotransmitter diseases.

Keith Hyland1.   

Abstract

The investigation of infants and children with suspected pediatric neurotransmitter diseases affecting serotonin and catecholamine metabolism is complicated because the measurement of metabolites in peripheral fluids is generally uninformative. Disorders that affect catecholamine (dopamine and norepinephrine) and serotonin neurotransmission, and that do not present with hyperphenylalaninemia, require that a lumbar puncture be performed and that specific metabolites be assessed in the collected cerebrospinal fluid. This review will discuss the disorders affecting catecholamine and serotonin biosynthesis, sample collection and handling, diagnostic methods and expected profiles, problems with diagnosis, and as yet to be described conditions that might be detected using current diagnostic methodologies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12891649     DOI: 10.1002/ana.10627

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  9 in total

1.  Neurotransmitter abnormalities and response to supplementation in SPG11.

Authors:  Adeline Vanderver; Davide Tonduti; Sarah Auerbach; Johanna L Schmidt; Sumit Parikh; Gordon C Gowans; Kelly E Jackson; Pamela L Brock; Marc Patterson; Michelle Nehrebecky; Rena Godfrey; Wadih M Zein; William Gahl; Camilo Toro
Journal:  Mol Genet Metab       Date:  2012-06-01       Impact factor: 4.797

2.  Diagnosis and treatment of neurotransmitter disorders.

Authors:  Phillip L Pearl; Thomas R Hartka; Jacob Taylor
Journal:  Curr Treat Options Neurol       Date:  2006-11       Impact factor: 3.598

Review 3.  Assessment of patients with isolated or combined dystonia: an update on dystonia syndromes.

Authors:  Victor S C Fung; H A Jinnah; Kailash Bhatia; Marie Vidailhet
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

4.  Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.

Authors:  A Vanderver; Y Hathout; J Maletkovic; E S Gordon; M Mintz; M Timmons; E P Hoffman; L Horzinski; F Niel; A Fogli; O Boespflug-Tanguy; R Schiffmann
Journal:  Neurology       Date:  2008-06-03       Impact factor: 9.910

Review 5.  Genetics of monoamine neurotransmitter disorders.

Authors:  Wai-Kwan Siu
Journal:  Transl Pediatr       Date:  2015-04

Review 6.  Pediatric neurotransmitter diseases.

Authors:  Phillip L Pearl; Denise D Wallis; K Michael Gibson
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

7.  Prevalence of inherited neurotransmitter disorders in patients with movement disorders and epilepsy: a retrospective cohort study.

Authors:  Saadet Mercimek-Mahmutoglu; Sarah Sidky; Keith Hyland; Jaina Patel; Elizabeth J Donner; William Logan; Roberto Mendoza-Londono; Mahendranath Moharir; Julian Raiman; Andreas Schulze; Komudi Siriwardena; Grace Yoon; Lianna Kyriakopoulou
Journal:  Orphanet J Rare Dis       Date:  2015-02-08       Impact factor: 4.123

8.  Secondary biogenic amine deficiencies: genetic etiology, therapeutic interventions, and clinical effects.

Authors:  Maja Tarailo-Graovac; Gabriella A Horvath; Clara D van Karnebeek; Ingrid Blydt-Hansen; Allison M Matthews; Vladimir Avramovic; Magda Price; Britt Drogemoller; Casper Shyr; Jessica Lee; Jill Mwenifumbo; Aisha Ghani; Sylvia Stockler; Jan M Friedman; Anna Lehman; Colin J Ross; Wyeth W Wasserman
Journal:  Neurogenetics       Date:  2021-07-02       Impact factor: 2.660

9.  The Utility of CSF for the Diagnosis of Primary and Secondary Monoamine Neurotransmitter Deficiencies.

Authors:  A B Burlina; A Celato; G Polo; C Edini; A P Burlina
Journal:  EJIFCC       Date:  2017-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.